Diskussionsleiter: D. Leistner (Frankfurt am Main), S. Störk (Würzburg), K. Werdan (Halle/Saale)
(P1346) | The Toll-like receptor 4 ligands S100A8 and S100A9 are crucial factors in viral cardiomyopathy |
P. M. Becher, D. Lindner, K. Savvatis, D. Westermann, T. Vogl, J. Roth, H.-P. Schultheiss, C. Tschöpe (Berlin, Münster) | |
(P1347) | Therapeutic suppression of parvovirus B19 replication with the thymidine analogon telbivudine improves clinical outcome in chronic myocarditis and reduces apoptosis in circulating angiogenic cells |
U. Kühl, C.-T. Bock, T. Zobel, C. Schmidt-Lucke, H.-P. Schultheiss (Berlin) | |
(P1348) | Antiviral and immunomodulatory effects restore titin function and extracellular matrix regulation in experimental myocarditis after IL-6 receptor inhibition |
P. M. Becher, D. Lindner, W. Linke, N. Hamdani, S. Van Linthout, D. Westermann, H.-P. Schultheiss, C. Tschöpe (Berlin, Bochum) | |
(P1349) | Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, B+ Tenascin-C and ED-A+ Fibronectin in Dilated Cardiomyopathy: Potential Markers for Risk Stratification? |
M. Franz, F. Reinbothe, D. Neri, K. Galler, K. Grün, C. Porrmann, G. Mall, P. Schlattmann, H.-R. Figulla, C. Jung, A. Berndt, F. Küthe (Jena, Darmstadt; Zürich, CH) | |
(P1350) | Galectin-3 Predicts Functional Capacity and Clinical Outcome in Heart Failure with Preserved Ejection Fraction (The Aldo-DHF Biomarker Substudy) |
K. Durstewitz, V. Holzendorf, R. Wachter, G. Gelbrich, R. Stahrenberg, G. Hasenfuß, B. Pieske, F. Edelmann (Göttingen, Leipzig, Würzburg; Graz, AT) | |
(P1351) | Endostatin serum levels are associated with the presence and severity of left ventricular diastolic dysfunction |
W. Dinh, J. Gülker, M. Coll Barroso, W. Nickl, M. Lankisch, R. Füth, T. Köhler, T. Scheffold, S. Schäfer, M. Seyfarth (Wuppertal, Düsseldorf, Freiburg im Breisgau, Gießen) | |
(P1352) | Adrenomedullin als Risikomarker bei Patienten mit akuter Dyspnoe |
A. C. Slagman, J. Searle, J. von Recum, C. Müller, J. Vollert, F. Holert, M. Stockburger, M. Möckel (Berlin, Henningsdorf, Nauen) | |
(P1353) | A functional polymorphism in the neuropeptide S receptor gene NPSR1 influences outcome in heart failure |
M. Kaspar, S. Kittel-Schneider, S. Störk, D. Berliner, G. Ertl, J. Deckert, A. Reif, C. E. Angermann (Würzburg, Hannover) | |
(P1354) | Kidney injury molecule-1 (KIM-1): additional prognostic value on top of NT-proBNP and hs-TnT in chronic heart failure |
S. Stadler, C. Birner, M. Resch, S. Buchner, M. Buesing, G. Riegger, A. Luchner, C. G. Jungbauer (Regensburg) | |
(P1355) | High sensitive procalcitonin predicts early re-hospitalisation for cardiac decompensation in systolic heart failure. |
C. Reichert, G. Güder, D. Berliner, S. Störk, G. Ertl, S. Brenner, C. E. Angermann (Würzburg, Hannover) | |
(P1356) | The influence of confounding factors in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure |
J. Kube, B. Bigalke, T. Wurster, E. A. Jankowska, P. Rozentryt, M. Cicoira, G. S. Filippatos, P. Ponikowski, W. Döhner, M. Gawaz, S. D. Anker, S. von Haehling (Berlin, Tübingen, Zabrze; Wroclaw, PL; Verona, IT; Athen, GR) |